Surface Oncology Buy Hold or Sell Recommendation

SURFDelisted Stock  USD 0.96  0.03  3.23%   
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Surface Oncology is 'Not Rated'. Macroaxis provides Surface Oncology buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SURF positions.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Note, we conduct extensive research on individual companies such as Surface and provide practical buy, sell, or hold advice based on investors' constraints. Surface Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Execute Surface Oncology Buy or Sell Advice

The Surface recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Surface Oncology. Macroaxis does not own or have any residual interests in Surface Oncology or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Surface Oncology's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Surface OncologyBuy Surface Oncology
Not Rated
For the selected time horizon Surface Oncology has a Risk Adjusted Performance of 0.1198, Jensen Alpha of 0.735, Total Risk Alpha of (0.06), Sortino Ratio of 0.1327 and Treynor Ratio of (0.71)
We provide advice to complement the current expert consensus on Surface Oncology. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Surface Oncology is not overpriced, please validate all Surface Oncology fundamentals, including its net income, target price, net asset, as well as the relationship between the current ratio and retained earnings . As Surface Oncology appears to be a penny stock we also recommend to double-check its price to book numbers.

Surface Oncology Trading Alerts and Improvement Suggestions

Surface Oncology is not yet fully synchronised with the market data
Surface Oncology has some characteristics of a very speculative penny stock
Surface Oncology has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 30 M. Net Loss for the year was (63.59 M) with loss before overhead, payroll, taxes, and interest of (37 M).
Surface Oncology currently holds about 156.65 M in cash with (59.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Surface Oncology Returns Distribution Density

The distribution of Surface Oncology's historical returns is an attempt to chart the uncertainty of Surface Oncology's future price movements. The chart of the probability distribution of Surface Oncology daily returns describes the distribution of returns around its average expected value. We use Surface Oncology price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Surface Oncology returns is essential to provide solid investment advice for Surface Oncology.
Mean Return
0.64
Value At Risk
-5.05
Potential Upside
8.51
Standard Deviation
4.39
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Surface Oncology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 56686 shares by Oneill Alison of Surface Oncology subject to Rule 16b-3 [view details]

Surface Oncology Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Surface . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Surface Oncology Buy or Sell Advice

When is the right time to buy or sell Surface Oncology? Buying financial instruments such as Surface Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Surface Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Printing and Publishing Thematic Idea Now

Printing and Publishing
Printing and Publishing Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Printing and Publishing theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Printing and Publishing Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Surface Stock

If you are still planning to invest in Surface Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surface Oncology's history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk